-
1
-
-
27544508598
-
Preventing chronic diseases: How many lives can we save?
-
Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005;366:1578-1582.
-
(2005)
Lancet
, vol.366
, pp. 1578-1582
-
-
Strong, K.1
Mathers, C.2
Leeder, S.3
Beaglehole, R.4
-
2
-
-
19944412446
-
Potential pitfalls of disease-specific guidelines for patients with multiple conditions
-
Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004;27:2870-2874.
-
(2004)
N Engl J Med
, vol.27
, pp. 2870-2874
-
-
Tinetti, M.E.1
Bogardus Jr., S.T.2
Agostini, J.V.3
-
3
-
-
23344445915
-
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance
-
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-724.
-
(2005)
JAMA
, vol.294
, pp. 716-724
-
-
Boyd, C.M.1
Darer, J.2
Boult, C.3
Fried, L.P.4
Boult, L.5
Wu, A.W.6
-
4
-
-
33750588902
-
Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: Diagnostic performance of cardiac biomarkers
-
Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Ben Hamda K, Ben Amor A, Najjar MF, Knani J. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 2006;174:990-996.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 990-996
-
-
Abroug, F.1
Ouanes-Besbes, L.2
Nciri, N.3
Sellami, N.4
Addad, F.5
Ben Hamda, K.6
Ben Amor, A.7
Najjar, M.F.8
Knani, J.9
-
5
-
-
24344473823
-
Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease
-
Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;18:1887-1894.
-
(2005)
Eur Heart J
, vol.18
, pp. 1887-1894
-
-
Rutten, F.H.1
Cramer, M.J.2
Grobbee, D.E.3
Sachs, A.P.4
Kirkels, J.H.5
Lammers, J.W.6
Hoes, A.W.7
-
6
-
-
0037162372
-
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) multinational study
-
McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 2002;106:416-422.
-
(2002)
Circulation
, vol.106
, pp. 416-422
-
-
McCullough, P.A.1
Nowak, R.M.2
McCord, J.3
Hollander, J.E.4
Herrmann, H.C.5
Steg, P.G.6
Duc, P.7
Westheim, A.8
Omland, T.9
Knudsen, C.W.10
-
7
-
-
0037116539
-
Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea
-
Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-209.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 202-209
-
-
Morrison, L.K.1
Harrison, A.2
Krishnaswamy, P.3
Kazanegra, R.4
Clopton, P.5
Maisel, A.6
-
8
-
-
33744457002
-
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
-
Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92:843-849.
-
(2006)
Heart
, vol.92
, pp. 843-849
-
-
Weber, M.1
Hamm, C.2
-
9
-
-
33744994082
-
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
-
Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-2560.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2554-2560
-
-
Mancini, G.B.1
Etminan, M.2
Zhang, B.3
Levesque, L.E.4
FitzGerald, J.M.5
Brophy, J.M.6
|